Pharmacological subclassification of α1-adrenoceptors in vascular smooth muscle

British Journal of Pharmacology

Volumn 99, Issue 1, 1990, Pages 197-201

  Muramatsu, I ^a   Ohmura, T ^a   Kigoshi, S ^a   Hashimoto, S ^a   Oshita, M ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ETHYL 3,4,5 TRIMETHOXY ALPHA [3 [[2 (2 METHOXYPHENOXY)ETHYL]AMINO]PROPYL]BENZENEACETONITRILE FUMARATE; CHLOROETHYLCLONIDINE; DEOXYCORTICOSTERONE ACETATE; DESIPRAMINE; NIFEDIPINE; NORADRENALIN; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; RECEPTOR SUBTYPE; YOHIMBINE;

ANIMAL CELL; AORTA; ARTICLE; CAROTID ARTERY; CLASSIFICATION; DOG; DRUG CONCENTRATION; FEMALE; GUINEA PIG; MALE; MESENTERIC ARTERY; MESENTERIC VEIN; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SAPHENOUS VEIN; SMOOTH MUSCLE CONTRACTILITY; VASCULAR SMOOTH MUSCLE;

EID: 0025186889     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1990.tb14678.x     Document Type: Article

References (24)

1. ARUNLAKSHANA, O. & SHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48–58.
2. BÜLBRING, E. & TOMITA, T. (1987). Catecholamine action on smooth muscle. Pharmacol. Rev., 39, 49–96.
3. DOXEY, J.C., SMITH, C.F.C. & WALKER, J.M. (1977). Selectivity of blocking agents for pre‐ and postsynaptic α‐adrenoceptors. Br. J. Pharmacol., 60, 91–96.
4. DREW, G.M. (1985). What do antagonists tell us about α‐adrenoceptors? Clin. Sci., 68 (Suppl. 10), 15s–19s.
5. FLAVAHAN, N.A. & VANHOUTTE, P.M. (1986). α‐Adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol. Sci., 7, 347–349.
6. FLAVAHAN, N.A., RIMELE, T.J., COOKE, J.P. & VANHOUTTE, P.M. (1984). Characterization of postjunctional alpha‐1 and alpha‐2 adrenoceptors activated by exogenous or nerve‐released norepinephrine in the canine saphenous vein. J. Pharmacol. Exp. Ther., 230, 699–705.
7. FOWLER, P.J., GROUS, M., PRICE, W. & MATTHEWS, W.D. (1984). Pharmacological differentiation of postsynaptic alpha adrenoceptors in the dog saphenous vein. J. Pharmacol. Exp. Ther., 229, 712–718.
8. FURCHGOTT, R.E. (1981). The requirement for endothelial cells in the relaxation of arteries by acetylcholine and some vasodilators. Trends Pharmacol. Sci., 2, 173–176.
9. HAN, C., ABEL, P.W. & MINNEMAN, K.P. (1987a). α 1 ‐Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca 2+ in smooth muscle. Nature, 329, 333–335.
10. HAN, C., ABEL, P.W. & MINNEMAN, K.P. (1987b). Heterogeneity of α 1 ‐adrenergic receptors revealed by chlorethylclonidine. Mol. Pharmacol., 32, 505–510.
11. HIEBLE, J.P., DeMARINIS, R.M., & MATTHEWS, W.D. (1986). Evidence for and against heterogeneity of α 1 ‐adrenoceptors. Life Sci., 38, 1339–1350.
12. JOHNSON, R.D. & MINNEMAN, K.P. (1987). Differentiation of α 1 ‐adrenergic receptors linked to phosphatidylinositol turnover and cyclic AMP accumulation in rat brain. Mol. Pharmacol., 31, 239–246.
13. KENAKIN, T.P. (1984). The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev., 36, 165–222.
14. LeCLERC, G., ROUOT, G., SCHWARTZ, J., VELLY, J. & WEMUTH, C.G. (1980). Studies on some para‐substituted clonidine derivatives that exhibit an α‐adrenoceptor stimulant activity. Br. J. Pharmacol., 71, 5–9.
15. McGRATH, J.C. (1982). Evidence for more than one type of postjunctional alpha‐adrenoceptor. Biochem. Pharmacol., 31, 467–484.
16. McGRATH, J., & WILSON, V. (1988). α‐Adrenoceptor subclassification by classical and response‐related methods: same question, different answers. Trends Pharmacol. Sci., 9, 162–165.
17. MINNEMAN, K.P. (1988). α 1 ‐Adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca 2+. Pharmacol. Rev., 40, 87–119.
18. MORROW, A.L. & CREESE, I. (1986). Characterization of α 1 ‐adrenergic receptor subtypes in rat brain: A reevaluation of [ 3 H] WB4101 and [ 3 H] prazosin binding. Mol. Pharmacol., 29, 321–330.
19. MURAMATSU, I. (1987). The effect of reserpine on sympathetic, purinergic neurotransmission in the isolated mesenteric artery of the dog: a pharmacological study. Br. J. Pharmacol., 91, 467–474.
20. MURAMATSU, I., KIGOSHI, S. & OSHITA, M. (1984). Non‐adrenergic nature of prazosin‐resistant, sympathetic contraction in dog mesenteric artery. J. Pharmacol. Exp. Ther., 229, 532–538.
21. OMOTE, S., KIGOSHI, S. & MURAMATSU, I. (1989). Selective inhibition by nifedipine of the purinergic component of neurogenic vasoconstriction in the dog mesenteric artery. Eur. J. Pharmacol., 160, 239–245.
22. OSHITA, M., IWANAGA, Y., HASHIMOTO, S., MORIKAWA, K. & MURAMATSU, I. (1988). Pharmacological studies on the selectivity of HV‐723, a new alpha‐1 adrenoceptor antagonist. Japan. J. Pharmacol., 47, 229–235.
23. RUFFOLO, R.R., Jr. (1982). Review: important concepts of receptor theory. J. Auton. Pharmacol., 2, 277–295.
24. SHEYS, E.M. & GREEN, R.D. (1972). A quantitative study of α‐adrenoceptors in the spleen and aorta of the rabbit. J. Pharmacol. Exp. Ther., 180, 317–325.